Brevan Howard Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-32,921
Closed -$477K 1362
2024
Q3
$477K Buy
+32,921
New +$477K ﹤0.01% 637